Last reviewed · How we verify

NCT06363838

Evaluation of Neuromuscular Morphometry of the Vaginal Wall

Completed Last updated 12 April 2024
What this trial tests

trial in Pelvic Organ Prolapse in 62 participants. Completed in 30 June 2020.

Timeline
1 December 2019
Primary endpoint
25 June 2020
30 June 2020

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment62
Start date1 December 2019
Primary completion25 June 2020
Estimated completion30 June 2020
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 40 to 75, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective study, women aged between 40 and 75 years who had not undergone any vaginal surgery and had not undergone any abdominal prolapse surgery were included. Thirty-one women diagnosed with rectocele on examination were included in the study group. Thirty-one patients who underwent vaginal intervention and hysterectomy for reasons other than rectocele (colposcopy, conization, etc.) without anterior or posterior wall prolapse were included in the control group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evaluation of Neuromuscular Morphometry of the Vaginal Wall Using Protein Gene Product 9.5 (Pgp 9.5) and Smooth Muscle α-Actin (Sma) in Patients with Posterior Vaginal Wall Prolapse.
    Çetin M, Güney G, Birge Ö, Arslan E, et al · · 2024 · cited 1× · PMID 38792998 · DOI 10.3390/medicina60050816

Verify or expand the search:

Other recruiting trials for Pelvic Organ Prolapse

Currently open trials in the same condition.

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06363838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing